524632.BO Stock Analysis
52
Uncovered
Shukra Pharmaceuticals Ltd is uncovered by Eyestock quantitative analysis.
Market cap $B
0.001
Dividend yield
0.56 %
Shares outstanding
43.79 B
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. The company is headquartered in Ahmedabad, Gujarat. The firm operates in two sectors: pharmaceutical and laboratory. The firm's manufacturing plant is situated in Rakanpur, Gandhinagar. The firm's product portfolio includes antibiotics (penicillin), anti-biotics (cephalosporin), anti-biotics, macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, analgesic (NASID), muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic. The firm is engaged in manufacturing general formulations, such as tablets, capsules and small volume parenteral.